Kamilla Kelemen

发表

Atrioventricular delay programming in cardiac resynchronization therapy devices: fixed or adaptive? A randomized monocenter trial.

H. Katus, Dierk Thomas, A. Bauer, 2012, Journal of electrocardiology.

Green tea flavonoid epigallocatechin-3-gallate (EGCG) inhibits cardiac hERG potassium channels.

A. Remppis, H. Katus, J. Greten, 2007, Biochemical and biophysical research communications.

Approaches for cardiovascular gene therapy in animal models

J. K. Donahue, Kamilla Kelemen, 2006 .

Indications for predismissal testing with arrhythmia-induction in patients receiving an implantable cardioverter defibrillator

H. Katus, A. Bauer, R. Becker, 2007, Clinical Research in Cardiology.

Biological Heart Rate Reduction Through Genetic Suppression of Gαs Protein in the Sinoatrial Node

H. Katus, Dierk Thomas, P. Lugenbiel, 2012, Journal of the American Heart Association.

Biventricular hypertrophy in dogs with chronic AV block: effects of cyclosporin A on morphology and electrophysiology.

H. Katus, A. Bauer, R. Becker, 2004, American journal of physiology. Heart and circulatory physiology.

Tridimensional activation patterns of acquired torsade-de-pointes-tachycardias in dogs with chronic AV-block

M. Vos, A. Bauer, R. Becker, 2004, Basic Research in Cardiology.

Pro- and antiarrhythmic effects of fast cardiac pacing in a canine model of acquired long QT syndrome

H. Katus, J. K. Donahue, A. Bauer, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Role of KATP channels in repetitive induction of ventricular fibrillation.

J. Dreyhaupt, H. Katus, A. Bauer, 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Gene therapy approaches to ventricular tachyarrhythmias.

J. K. Donahue, T. Sasano, Kamilla Kelemen, 2007, Journal of electrocardiology.

Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3: a pre-clinical pilot study.

H. Katus, Dierk Thomas, P. Lugenbiel, 2013, European heart journal.

Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model.

M. Koch, H. Katus, Dierk Thomas, 2011, Cardiovascular research.

Genetic suppression of Gαs protein provides rate control in atrial fibrillation

H. Katus, Dierk Thomas, P. Lugenbiel, 2012, Basic Research in Cardiology.

Effects of protein kinase C activation on cardiac repolarization and arrhythmogenesis in Langendorff-perfused rabbit hearts.

M. Koch, H. Katus, A. Bauer, 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Heterogeneous repolarization creates ventricular tachycardia circuits in healed myocardial infarction scar

X. Wan, I. Greener, J. K. Donahue, 2022, Nature Communications.

Ventricular tachycardia from the healed myocardial infarction scar: validation of an animal model and utility of gene therapy.

J. K. Donahue, T. Sasano, I. Greener, 2009, Heart rhythm.

Genetic suppression of atrial fibrillation using a dominant-negative ether-a-go-go-related gene mutant.

H. Katus, Dierk Thomas, A. Bauer, 2012, Heart rhythm.

Heterogeneous repolarization creates ventricular tachycardia circuits in healed myocardial infarction scar

S. Parajuli, J. K. Donahue, X. Wan, 2022, Nature communications.

Abstract 2101: Genetic Ablation of Atrial Fibrillation in Pigs With Atrial Fibrillation

M. Koch, H. Katus, A. Bauer, 2009 .